1. Home
  2. STKL vs SPRY Comparison

STKL vs SPRY Comparison

Compare STKL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunOpta Inc.

STKL

SunOpta Inc.

HOLD

Current Price

$6.49

Market Cap

769.4M

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.18

Market Cap

833.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKL
SPRY
Founded
1973
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
769.4M
833.1M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
STKL
SPRY
Price
$6.49
$8.18
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$7.50
$40.00
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
186.67
N/A
EPS
0.13
N/A
Revenue
$817,715,000.00
$84,278,000.00
Revenue This Year
$6.84
$90.76
Revenue Next Year
$33.58
$81.70
P/E Ratio
$49.85
N/A
Revenue Growth
12.99
N/A
52 Week Low
$3.32
$6.66
52 Week High
$6.94
$18.63

Technical Indicators

Market Signals
Indicator
STKL
SPRY
Relative Strength Index (RSI) 65.59 47.22
Support Level $6.43 $8.05
Resistance Level $6.52 $8.63
Average True Range (ATR) 0.02 0.37
MACD -0.02 0.05
Stochastic Oscillator 50.00 55.36

Price Performance

Historical Comparison
STKL
SPRY

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own proprietary brands, including SOWN, Dream, and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut, and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada, and Others, out of which it derives maximum revenue from U.S.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: